Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
22.98 USD | +5.08% | +10.64% | +59.81% |
May. 14 | Kura Oncology Enrolls 85 Patients in Ziftomenib Trial for Leukemia Drug | MT |
May. 14 | Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+59.81% | 1.67B | |
+8.29% | 113B | |
+10.21% | 106B | |
+0.41% | 22.27B | |
-11.90% | 22.22B | |
-5.99% | 19.43B | |
-37.36% | 17.87B | |
-5.17% | 17.24B | |
+7.70% | 14.29B | |
+37.65% | 12.52B |
- Stock Market
- Equities
- KURA Stock
- News Kura Oncology, Inc.
- Top Premarket Gainers